Published: Mar 1, 2026
Written by Klarity Editorial Team
Published: Mar 1, 2026

If you’re struggling with Binge Eating Disorder (BED), you’ve probably wondered whether telehealth could be a practical way to access treatment—especially medication. The good news: yes, you can get BED medication prescribed through telehealth in most of the United States, and the process is often more straightforward than many people realize.
Whether you’re balancing a busy schedule, living in an area with limited mental health specialists, or simply prefer the privacy and convenience of virtual care, telehealth offers a legitimate pathway to evidence-based treatment. This guide breaks down everything you need to know about accessing BED medications remotely, from legal requirements to what you can expect during your first appointment.
Binge Eating Disorder is the most common eating disorder in the United States, yet it remains underdiagnosed and undertreated. According to DSM-5 criteria, BED involves recurrent episodes of eating an unusually large amount of food within a discrete period (typically two hours), accompanied by a sense of loss of control. To meet diagnostic criteria, these episodes must occur at least once weekly for three months and are associated with significant distress—but importantly, not followed by compensatory behaviors like purging or excessive exercise.
While psychotherapy (particularly cognitive-behavioral therapy and interpersonal therapy) remains the gold standard for BED treatment, medication can play an important supporting role. Currently, only one medication—lisdexamfetamine (Vyvanse)—has FDA approval specifically for moderate-to-severe BED. However, because Vyvanse is a controlled stimulant with tighter telehealth prescribing restrictions, many providers turn to off-label medications that have shown promise in clinical studies and can be prescribed more easily via telemedicine.
The two most commonly prescribed off-label medications for BED through telehealth platforms are:
Both medications are non-controlled substances, which makes them fully accessible through legitimate telehealth services nationwide.
Here’s where many people get confused: federal drug laws distinguish sharply between controlled substances (like ADHD stimulants, opioids, and benzodiazepines) and non-controlled prescription medications (like Topamax and Wellbutrin).
The Ryan Haight Act—a 2008 federal law designed to prevent online ‘pill mills’—requires an in-person medical evaluation before controlled substances can be prescribed via telemedicine. However, this law never applied to non-controlled medications. During the COVID-19 pandemic, even those controlled-substance restrictions were temporarily waived, and those flexibilities have been extended multiple times—most recently through December 31, 2026.
For the medications used to treat BED via telehealth (topiramate and bupropion), there is no federal requirement for an in-person visit. As long as your provider is licensed in your state and conducts an appropriate clinical evaluation, they can legally prescribe these medications entirely through virtual care.
While federal law sets the baseline, individual states add their own telehealth regulations. The good news? Most states have permanently adopted policies that support remote prescribing for non-controlled medications.
The majority of states—including California, New York, Texas, Florida, Delaware, Michigan, Wisconsin, and South Carolina—have no mandatory in-person visit requirement for prescribing non-controlled medications like those used for BED. In these states, a comprehensive telehealth evaluation (typically via live video) satisfies the legal standard for establishing a provider-patient relationship.
California even went a step further in 2025 with AB 1503, explicitly clarifying that a ‘good faith exam’ can be conducted via asynchronous telehealth (like online questionnaires combined with provider review), as long as it meets the appropriate standard of care.
A handful of states—notably Alabama, Georgia, and New Hampshire—require that patients receiving ongoing telehealth care be seen in person periodically, typically within 12 months of starting treatment.
For example, Alabama’s telehealth law specifies that if a patient receives more than four telehealth visits for the same condition within a year, an in-person evaluation must occur within that 12-month period. However, this requirement can often be satisfied by any collaborating healthcare provider, not necessarily your telehealth prescriber. If you see a primary care doctor or therapist in person during that time, that may fulfill the requirement.
Georgia requires at least an annual attempt at an in-person exam for continued telemedicine care, and New Hampshire’s 2025 legislation (SB 252) mandates annual in-person follow-up for patients on certain Schedule II-IV controlled substances—though again, this doesn’t typically affect non-controlled BED medications.
Many states maintain Prescription Drug Monitoring Programs (PDMPs or PMPs) that track controlled substance prescriptions to prevent abuse and diversion. However, since topiramate and bupropion are not controlled substances, most states don’t legally require providers to check the PMP before prescribing them.
That said, responsible telehealth providers may still review your medication history as a clinical best practice—to check for potential drug interactions or ensure you’re not already taking a similar medication from another provider.
Any licensed prescriber can potentially provide telehealth treatment for BED, but there are important differences in scope of practice:
Medical doctors and doctors of osteopathy can prescribe these medications in all 50 states without restrictions (beyond standard licensing requirements).
The landscape for NP prescribing authority has evolved dramatically. As of 2025, 34 states plus the District of Columbia grant Nurse Practitioners full practice authority—meaning they can evaluate, diagnose, and prescribe medications independently without physician oversight.
Recent additions to the full-practice-authority list include Wisconsin (August 2025), Michigan (2025), Louisiana, and Kansas. In these states, an NP working for a telehealth platform like Klarity Health can conduct your entire evaluation and prescribe BED medications completely independently.
In other states—including Texas, Florida, Georgia, and Alabama—NPs work under collaborative practice agreements with physicians. Practically speaking, this rarely affects your patient experience; it’s a regulatory requirement handled behind the scenes. Your NP can still evaluate you, prescribe medication, and manage your ongoing care—they just do so under a formal agreement with a supervising physician.
PAs can prescribe non-controlled medications in all states, though they typically work under physician supervision. Like with NPs in collaborative states, this supervision requirement doesn’t usually impact your access to care through telehealth platforms.
A legitimate telehealth evaluation for BED should be thorough and comprehensive—not a quick five-minute questionnaire followed by an automatic prescription.
Your first appointment will typically last 30-45 minutes and include:
Detailed Medical History: Expect questions about your overall health, current medications, past psychiatric treatment, substance use history, and any medical conditions (especially seizure disorders, eating disorder history, pregnancy status, and cardiovascular issues).
BED Diagnostic Assessment: Your provider will ask specific questions about your eating patterns—how often you experience binge episodes, what triggers them, whether you feel a loss of control, and whether you engage in compensatory behaviors afterward. They may use standardized questionnaires like the Binge Eating Scale (BES) or Eating Disorder Examination Questionnaire (EDE-Q).
Mental Health Screening: Since BED frequently co-occurs with depression, anxiety, ADHD, and other conditions, your provider will screen for these. They’ll also assess for suicidal thoughts, particularly important given the black-box warning on bupropion for increased suicide risk in people under 25.
Treatment Goals and Expectations: A good provider will discuss all treatment options—not just medication. This should include psychotherapy (especially cognitive-behavioral therapy), nutritional counseling, and support groups. Medication should be positioned as one tool in a comprehensive treatment plan, not a standalone solution.
Don’t be surprised when your provider asks to verify your identity and location. This isn’t intrusive—it’s required by many state laws and ensures your provider is licensed to treat patients in your state. Reputable platforms use secure methods to confirm you are who you say you are and that you’re located in a state where the provider holds an active license.
Your provider will also document that they’ve:
All of this goes into a secure electronic health record, just as it would in a traditional clinic setting.
How it works: Originally developed for epilepsy and migraine prevention, topiramate appears to help with BED by affecting neurotransmitters that regulate appetite and impulse control.
Typical approach: Providers usually start at a low dose (25mg) and gradually increase over several weeks to minimize side effects. The target dose for BED is often 100-200mg daily, significantly lower than doses used for seizures.
Important considerations:
Supply limits: Since topiramate is non-controlled, providers can typically prescribe up to a 90-day supply with refills, though many start with 30 days during the initial titration period.
How it works: This atypical antidepressant affects dopamine and norepinephrine. While its exact mechanism in BED isn’t fully understood, it may help reduce binge episodes while also treating co-occurring depression.
Typical approach: Extended-release formulations (Wellbutrin XL or SR) are preferred to reduce seizure risk. Starting doses are usually 150mg daily, potentially increasing to 300mg or (less commonly) 450mg.
Important contraindications:
Black-box warning: Like all antidepressants, bupropion carries an FDA warning about increased suicidal thinking and behavior in children, adolescents, and young adults (under 25). Close monitoring is essential, especially in the first few months of treatment.
Other considerations:
Supply limits: Non-controlled status allows for longer prescriptions (up to 90 days with refills), though initial prescriptions are often for 30 days while assessing tolerance and response.
| Feature | Topiramate (Topamax) | Bupropion (Wellbutrin) |
|---|---|---|
| DEA Schedule | None (non-controlled) | None (non-controlled) |
| FDA Approval for BED | No (off-label use) | No (off-label use) |
| Primary FDA Indications | Seizures, migraine prevention | Depression, smoking cessation |
| Typical Starting Dose | 25mg daily | 150mg daily (XL formulation) |
| Target Dose Range for BED | 100-200mg daily | 150-300mg daily |
| Titration Required | Yes (gradual increase) | Sometimes (depends on formulation) |
| Major Contraindications | Pregnancy, metabolic acidosis | Bulimia/anorexia history, seizure disorder |
| Common Side Effects | Cognitive slowing, tingling, weight loss | Dry mouth, insomnia, agitation |
| Pregnancy Category | High risk (birth defects) | Moderate caution needed |
| Typical Prescription Length | 30-90 days with refills | 30-90 days with refills |
| Requires PMP Check | No (recommended only) | No (recommended only) |
While telehealth expands access significantly, it’s not appropriate for everyone. Responsible providers will screen for these situations:
If you’re experiencing suicidal thoughts, severe depression, or other psychiatric emergencies, you need immediate in-person evaluation—potentially including emergency department care. Telehealth is for stable outpatient treatment, not crisis intervention.
Certain situations require physical examination:
As mentioned, bupropion is contraindicated in bulimia and anorexia nervosa. If you have a history of these conditions—even if currently in remission—your provider needs to carefully weigh risks and may choose alternative treatments.
Topiramate’s significant teratogenic (birth defect) risk makes it unsuitable during pregnancy. Providers will typically require negative pregnancy tests and reliable contraception before prescribing. For pregnant or breastfeeding patients, therapy-focused approaches are generally safer.
If clinical evaluation suggests you would benefit from lisdexamfetamine (Vyvanse)—the only FDA-approved medication for BED—telehealth access becomes more complicated due to controlled-substance regulations. While technically possible under current temporary federal rules (extended through 2026), many telehealth platforms choose not to prescribe stimulants remotely due to regulatory complexity and abuse potential. You may be referred to an in-person specialist.
Successful telehealth requires reliable internet access, a private space for video visits, and the ability to pick up prescriptions from a pharmacy. If these aren’t available, community health centers offering in-person care may be more appropriate.
The telehealth industry has matured significantly, but not all online services maintain the same standards. Here’s what to look for:
Guaranteed prescriptions before evaluation: Legitimate providers never promise medication before conducting a proper assessment. If a service advertises ‘guaranteed prescription’ or ‘get your meds today,’ that’s a warning sign.
Minimal clinical questioning: A thorough BED evaluation takes time. If you’re asked only a handful of yes/no questions and offered a prescription within minutes, the service isn’t meeting appropriate standards of care.
No discussion of alternatives: Medication should be presented as one option within a comprehensive treatment plan. Providers who skip over therapy, lifestyle modifications, or nutritional counseling may be more interested in profit than outcomes.
Pressure to choose specific medications: You should feel informed and empowered in medication selection, not pressured toward the most expensive or profitable option.
Direct medication sales: Legitimate services send prescriptions to regular pharmacies—not their own internal pharmacy. If a company wants to sell you medication directly (rather than sending a prescription to CVS, Walgreens, or a legitimate mail-order pharmacy), be very cautious.
Comprehensive intake: Initial evaluations lasting 30+ minutes with detailed medical and psychiatric history.
Licensed, credentialed providers: Clear information about who you’ll see, their credentials, and their state licensure. At Klarity Health, for example, all providers are licensed medical professionals (MDs, DOs, NPs, or PAs) with expertise in mental health and eating disorders.
Informed consent process: Thorough explanation of off-label use (when applicable), potential side effects, contraindications, and treatment alternatives.
Follow-up structure: Clear scheduling of follow-up appointments—typically at 2-4 weeks initially, then monthly or bimonthly. No legitimate provider prescribes and disappears.
Accessible communication: Between-visit messaging or nurse lines for questions or concerns. While not every question needs a real-time response, you should have a way to reach your care team.
Transparent pricing: Clear information about visit costs, whether insurance is accepted, and what you’ll pay. Klarity Health, for instance, accepts both insurance and offers transparent cash-pay pricing for those without coverage or who prefer not to use insurance.
Pharmacy integration: Electronic prescriptions sent to your choice of pharmacy, with clear instructions on how to transfer prescriptions if needed.
Klarity Health has built its telehealth platform around the principles that make remote BED treatment both effective and safe. Here’s what sets the approach apart:
Provider availability: Unlike many traditional practices with multi-week wait times, Klarity typically offers appointments within days—sometimes as soon as the next day. This rapid access is crucial for patients ready to start treatment.
Flexible scheduling: Evening and weekend appointments accommodate work schedules and family obligations that make traditional office visits challenging.
Transparent pricing: Whether you’re using insurance or paying out-of-pocket, you’ll know the cost upfront. There are no surprise bills or hidden fees—just straightforward pricing for evaluation and ongoing care.
Dual payment options: Klarity accepts most major insurance plans, but also offers accessible cash-pay rates for those without coverage or who prefer to keep treatment private.
Coordinated care philosophy: While Klarity providers can prescribe medication, they recognize that comprehensive BED treatment often benefits from a team approach. Providers can coordinate with your therapist, dietitian, or primary care doctor (with your permission) to ensure everyone is working toward the same goals.
Evidence-based protocols: Medication selection, dosing, and monitoring follow established clinical guidelines and current research—not aggressive sales targets.
Getting a prescription is just the beginning of treatment. Here’s what successful ongoing care looks like:
First check-in (2-4 weeks): Your provider will assess how you’re tolerating the medication, whether you’re experiencing side effects, and if any dose adjustment is needed. For topiramate, this often involves increasing the dose as part of the titration plan.
Monthly visits (first 3 months): During the early phase, monthly check-ins help optimize dosing and monitor for both positive effects (reduction in binge frequency) and any concerning side effects.
Maintenance phase (every 2-3 months): Once stable on an effective dose, visits can typically spread out to every 8-12 weeks. However, some states with periodic in-person requirements (Alabama, Georgia, New Hampshire) may require at least annual in-person visits even during maintenance.
Your provider will track several metrics:
Be prepared to honestly report your eating patterns, including any binge episodes. Your provider can only help if they know what’s really happening.
Because these are non-controlled medications, providers can typically authorize refills for 6-12 months (depending on state pharmacy laws) without requiring a new prescription each month. However, this doesn’t mean you skip follow-up appointments—the prescription may have refills, but ongoing monitoring appointments are still essential.
Most telehealth platforms use electronic prescribing systems that can send refills to your pharmacy with a quick message or automatic renewal at scheduled times, eliminating the need for calling in each month.
Here’s an important point that sometimes gets lost in discussions about medication: medication works best when combined with psychotherapy for BED. Research consistently shows that cognitive-behavioral therapy (CBT) specifically adapted for BED produces the highest remission rates, and combining medication with therapy often yields better results than either alone.
Your telehealth medication provider should encourage—and ideally facilitate—connection with a therapist. Some integrated platforms like Klarity Health can coordinate both medication management and therapy through the same system, ensuring your providers are communicating and working together.
Other helpful complementary treatments:
One common question: ‘Will my insurance cover telehealth BED treatment?’
The short answer: Most insurance plans now cover telehealth visits at parity with in-person visits, thanks to pandemic-era policy changes that have largely been made permanent.
Medication coverage: Whether your insurance covers topiramate or bupropion depends on your specific formulary. The good news is that both medications are available as generics, making them relatively inexpensive even without insurance. Generic topiramate typically costs $10-30 per month, and generic bupropion runs $15-40, though prices vary by pharmacy and location.
Prior authorization: Some insurance plans require prior authorization before covering off-label uses. Your provider’s office should be able to handle this paperwork, though it can delay treatment by a week or two. If prior auth is denied, you can often pay cash for generics at reasonable prices while appealing the decision.
Cash-pay telehealth: If you don’t have insurance or prefer not to use it, platforms like Klarity Health offer transparent cash pricing for visits—often in the $99-199 range for initial evaluations and $79-149 for follow-ups. When combined with low-cost generic medications, the total monthly cost can be quite manageable compared to traditional in-person specialist care.
Telehealth visits are protected by the same HIPAA privacy rules as in-person care. Your video sessions use encrypted connections, your medical records are stored securely, and information cannot be shared without your written consent (except in narrow legal exceptions like imminent danger situations).
Who can see your records:
Who cannot see your records:
If privacy is a concern—perhaps you’re worried about family members seeing mail from a provider or charges on insurance statements—ask about options. Many platforms offer discreet billing descriptions and can communicate via secure patient portals rather than mail.
The telehealth regulatory landscape continues evolving. Here are the most recent changes relevant to BED treatment:
Federal extensions: The DEA extended COVID-era telehealth prescribing flexibilities for controlled substances through December 31, 2026. While this primarily affects medications like Vyvanse (which some providers might prescribe via telehealth under these temporary rules), it signals continued federal support for telehealth access.
State expansions: Several states expanded NP practice authority in 2025, including Wisconsin and Michigan joining the full-practice-authority ranks. This increases the pool of providers who can independently manage BED treatment via telehealth.
State telehealth clarifications: California’s AB 1503 explicitly validated asynchronous telehealth for prescribing, and New Hampshire’s SB 252 modernized that state’s controlled-substance telehealth rules (though with annual in-person requirements).
Enforcement actions: Federal authorities have cracked down on irresponsible telehealth prescribing, particularly controlled substances. The indictment of executives from a questionable ADHD telehealth startup for allegedly prescribing stimulants without proper evaluations sent a clear message: shortcuts and pill-mill behavior will be prosecuted. This actually benefits patients seeking legitimate care—it pushes the industry toward higher standards and weeds out bad actors.
Can I use telehealth for BED treatment if I live in a rural area?
Absolutely. This is one of telehealth’s biggest advantages—connecting patients in underserved areas with specialists who might be hundreds of miles away. As long as your provider is licensed in your state (not just their home state), they can treat you remotely regardless of your location within that state.
What if I’m traveling or move to another state?
Your provider must be licensed in the state where you’re physically located at the time of the appointment. If you’re temporarily traveling, check with your provider beforehand—many hold licenses in multiple states. If you permanently move, you’ll need to establish care with a provider licensed in your new state. Some telehealth platforms operate in dozens of states and can potentially transfer your care to a new provider within their network.
Do I need special technology for telehealth visits?
Not really. A smartphone, tablet, or computer with a camera, microphone, and reliable internet connection is sufficient. Most platforms use simple video conferencing through a web browser or app—no technical expertise required.
Can I use telehealth if I’m on other medications?
Yes, but full disclosure is critical. Your provider needs to know every medication (including over-the-counter drugs and supplements) you’re taking to check for interactions. This is especially important with bupropion, which interacts with MAO inhibitors and other antidepressants.
How quickly will medication work for BED?
This varies by person and medication. Some patients notice reduced binge urges within 2-4 weeks, while others may need 8-12 weeks at a therapeutic dose. Topiramate requires gradual dose increases, so full effect may take longer. Patience and consistent follow-up are essential—don’t give up if you don’t see immediate results.
What if the medication doesn’t help or I have bad side effects?
This is exactly why regular follow-up is important. If side effects are intolerable or the medication isn’t effective after a reasonable trial, your provider can adjust the dose, switch medications, or explore alternative approaches. Never just stop medications abruptly, especially topiramate—always consult your provider about safe discontinuation.
Can telehealth providers prescribe Vyvanse (lisdexamfetamine) for BED?
Technically yes under current temporary DEA rules (through end of 2026), but many telehealth platforms choose not to prescribe controlled stimulants remotely due to regulatory complexity and heightened scrutiny. If you’re specifically interested in Vyvanse, ask your telehealth provider about their policy. You may need an in-person specialist referral.
Will my primary care doctor know I’m getting BED treatment via telehealth?
Only if you authorize your telehealth provider to share information with them—which is often a good idea for coordinated care. With your consent, your providers can communicate to ensure everyone knows about all your medications and treatments. Without your consent, your primary doctor won’t be informed.
If you’re ready to explore telehealth treatment for Binge Eating Disorder, here’s a simple action plan:
1. Verify your state allows telehealth prescribing for the providers you’re considering. (As we’ve covered, most states do—but it’s worth confirming, especially if you live in Alabama, Georgia, or New Hampshire where periodic in-person visits may be needed.)
2. Research reputable telehealth platforms. Look for providers who:
Klarity Health checks all these boxes and specializes in mental health conditions including eating disorders, with providers available across most U.S. states.
3. Prepare for your evaluation. Before your first appointment:
4. Be honest and thorough during your evaluation. Your provider can only help with accurate information. Discuss:
5. Commit to the process. BED treatment requires patience and persistence. Medication helps, but it’s not a magic bullet. Expect to:
6. Advocate for yourself. If something isn’t working—whether it’s medication side effects, difficulty reaching your provider, or concerns about your treatment plan—speak up. Good providers welcome questions and adjust treatment based on your feedback.
Binge Eating Disorder is a serious but treatable condition. For years, many people struggled to access specialized care due to distance, cost, stigma, or provider shortages. Telehealth has fundamentally changed this landscape, making evidence-based treatment—including medication when appropriate—available to nearly anyone with an internet connection.
The medications we’ve discussed—topiramate and bupropion—aren’t perfect solutions, and they don’t work for everyone. But for many people with BED, they provide meaningful relief from binge urges while therapy and other interventions address the underlying issues. The combination of medication and psychotherapy offers the best chance of long-term recovery.
As of 2026, the legal framework supporting telehealth prescribing is more robust than ever. Federal policies remain supportive, most states have permanently adopted telehealth-friendly regulations, and enforcement efforts are raising standards while maintaining access. Whether you’re in a major city or a small rural town, quality BED treatment via telehealth is not just legal—it’s increasingly accessible.
If you’re struggling with Binge Eating Disorder, you don’t have to face it alone, and you don’t have to wait weeks or months for an in-person appointment with a distant specialist. Telehealth platforms like Klarity Health offer a faster, more convenient pathway to care, with licensed providers ready to conduct thorough evaluations and create personalized treatment plans that fit your life.
The first step is often the hardest. But reaching out—scheduling that initial appointment—can be the beginning of genuine change. Recovery from BED is possible, and telehealth has made that possibility more accessible than ever before.
Verified as of: January 4, 2026
Key Sources:
U.S. Department of Health and Human Services. ‘DEA Extends Telehealth Prescribing Flexibilities Through December 31, 2026.’ HHS Press Office, January 2026. www.hhs.gov
Sheppard, Mullin, Richter & Hampton LLP. ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions.’ Healthcare Law Blog, August 2025. www.sheppardhealthlaw.com
Center for Connected Health Policy. ‘State Telehealth Laws and Reimbursement Policies: Online Prescribing Database.’ Updated December 2025. www.cchpca.org
Health Jobs Nationwide. ‘State-by-State Guide: Expanding Roles for PAs and NPs (Updated 2025).’ Healthcare Workforce Blog, October 2025. blog.healthjobsnationwide.com
U.S. Food and Drug Administration/DailyMed. ‘Bupropion Hydrochloride Extended-Release Tablets – Full Prescribing Information.’ National Library of Medicine, 2025. dailymed.nlm.nih.gov
Find the right provider for your needs — select your state to find expert care near you.